(Reuters) -AstraZeneca said on Tuesday that U.S. regulators have approved its precision drug Datroway to treat a type of lung ...

Prior to that and some other roles, Zook was a top official at pharmaceutical giant AstraZeneca, where he held global P&L responsibility for all of AZ's brands and markets, representing over $30 ...

At that time, Tony Zook, an independent board member ... Zook was as an executive vice president for commercial operations at AstraZeneca, where he held responsibility for all of its brands ...

Tony Zook, an independent board member since 2023 ... Zook was Executive Vice President of Global Commercial Operations at AstraZeneca (AZ), where he held global P&L responsibility for all of AZ's ...

At that time, Tony Zook, an independent board member ... Zook was as an executive vice president for commercial operations at AstraZeneca, where he held responsibility for all of its brands ...

Tony Zook, an independent board member since 2023 ... Zook was Executive Vice President of Global Commercial Operations at AstraZeneca (AZ), where he held global P&L responsibility for all ...

Tony Zook, an independent board member since 2023 ... Zook was executive vice president of global commercial operations at AstraZeneca, where he held global profit and loss responsibility for all of ...

Under Mr. Zook’s leadership, AstraZeneca commercialized ten blockbuster ... “I am delighted to have Tony assume the newly formed role of Executive Chairman of Voltron’s Board of Directors.

Under Mr. Zook’s leadership, AstraZeneca commercialized ten blockbuster brands ... Laidlaw Venture Partners. “The addition of Tony will help accelerate our efforts to drive growth and value in our ...